GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | Mapk8 | decreases expression | EXP | | 6480464 | CTD | Folic Acid results in decreased expression of MAPK8 mRNA | PMID:25629700 | Mapk8 | increases phosphorylation | EXP | | 6480464 | CTD | Folic Acid results in increased phosphorylation of MAPK8 protein | PMID:31447676 | Mapk8 | multiple interactions | EXP | | 6480464 | CTD | [pyrazolanthrone co-treated with 6,7-dimethyl-2-(2E)-3-(1-methyl-2-phenyl-1H-pyrrolo(2,3-b)pyridin-3-yl-prop-2-enoyl)-1,2,3,4-tetrahydroisoquinoline hydrochloride] inhibits the reaction [Folic Acid results in increased phosphorylation of MAPK8 protein]; Folic Acid inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in decreased phosphorylation of MAPK8 protein]; Folic Acid inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK8 protein]; pyrazolanthrone inhibits the reaction [Folic Acid results in increased phosphorylation of MAPK8 protein] | PMID:21528358 PMID:27738387 PMID:31447676 | |
Go Back to source page | Continue to Ontology report |